304 related articles for article (PubMed ID: 3039515)
21. Importance of receptor usage, Fli1 activation, and mouse strain for the stem cell specificity of 10A1 murine leukemia virus leukemogenicity.
Rodenburg M; Fischer M; Engelmann A; Harbers SO; Ziegler M; Löhler J; Stocking C
J Virol; 2007 Jan; 81(2):732-42. PubMed ID: 17079317
[TBL] [Abstract][Full Text] [Related]
22. Abelson murine leukemia virus variants with increased oncogenic potential.
Murtagh K; Skladany G; Hoag J; Rosenberg N
J Virol; 1986 Nov; 60(2):599-606. PubMed ID: 3021994
[TBL] [Abstract][Full Text] [Related]
23. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
Green PL; Kaehler DA; McKearn J; Risser R
Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
[TBL] [Abstract][Full Text] [Related]
24. Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line.
Hartley JW; Evans LH; Green KY; Naghashfar Z; Macias AR; Zerfas PM; Ward JM
Retrovirology; 2008 Jan; 5():1. PubMed ID: 18177500
[TBL] [Abstract][Full Text] [Related]
25. Blast colonies containing hemopoietic progenitor cells can give rise to Abelson virus (A-MuLV)-transformed cell lines.
Wong PM; Chung SW; Raefsky E; Eaves CJ; Nienhuis AW
Exp Hematol; 1988 Jan; 16(1):5-11. PubMed ID: 2446900
[TBL] [Abstract][Full Text] [Related]
26. Clonal dominance and progression in Abelson murine leukemia virus lymphomagenesis.
Green PL; Kaehler DA; Risser R
J Virol; 1987 Jul; 61(7):2192-7. PubMed ID: 3035219
[TBL] [Abstract][Full Text] [Related]
27. Effects of murine leukemia virus infection on long-term hematopoiesis in vitro emphasized by increased survival of bone marrow cultures derived from BALB/Mo mice.
Greenberger JS; Shadduck RK; Jaenisch R; Waheed A; Sakakeeny MA
Cancer Res; 1981 Sep; 41(9 Pt 1):3556-65. PubMed ID: 6266658
[TBL] [Abstract][Full Text] [Related]
28. Abelson murine leukemia virus mutants with alterations in the virus-specific P120 molecule.
Rosenberg N; Witte ON
J Virol; 1980 Jan; 33(1):340-8. PubMed ID: 6245237
[TBL] [Abstract][Full Text] [Related]
29. Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus.
Starkey CR; Lobelle-Rich PA; Granger SW; Brightman BK; Fan H; Levy LS
J Virol; 1998 Feb; 72(2):1078-84. PubMed ID: 9445002
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
Schenk PJ; Howe ML
J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
[TBL] [Abstract][Full Text] [Related]
31. Chromatin conformation of integrated Moloney leukemia virus DNA sequences in tissues of BALB/Mo mice and in virus-infected cell lines.
Breindl M; Bacheler L; Fan H; Jaenisch R
J Virol; 1980 May; 34(2):373-82. PubMed ID: 7373714
[TBL] [Abstract][Full Text] [Related]
32. Transformation of NIH3T3 cells by A-MuLV proviral DNA: effect of plasmid linearization and carrier DNA on transformation efficiency.
Shore SK; Reddy EP
Oncogene; 1989 Nov; 4(11):1411-3. PubMed ID: 2554240
[TBL] [Abstract][Full Text] [Related]
33. Effect of murine host genotype on MCF virus expression, latency, and leukemia cell type of leukemias induced by Friend murine leukemia helper virus.
Chesebro B; Portis JL; Wehrly K; Nishio J
Virology; 1983 Jul; 128(1):221-33. PubMed ID: 6308893
[TBL] [Abstract][Full Text] [Related]
34. Comparison of three recombinant murine leukemia viruses carrying the v-src oncogene of avian sarcoma virus: differences in in vitro transformation and in vivo pathogenicity.
Feuerman MH; Lee WT; Pattengale PK; Fan H
Mol Carcinog; 1988; 1(1):57-66. PubMed ID: 2855603
[TBL] [Abstract][Full Text] [Related]
35. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
Rees-Jones RW; Goff SP
J Virol; 1988 Mar; 62(3):978-86. PubMed ID: 2828693
[TBL] [Abstract][Full Text] [Related]
36. Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism.
Pierce JH; Di Fiore PP; Aaronson SA; Potter M; Pumphrey J; Scott A; Ihle JN
Cell; 1985 Jul; 41(3):685-93. PubMed ID: 2988783
[TBL] [Abstract][Full Text] [Related]
37. Moloney murine leukemia virus-induced tumors: recombinant proviruses in active chromatin regions.
van der Putten H; Quint W; Verma IM; Berns A
Nucleic Acids Res; 1982 Jan; 10(2):577-92. PubMed ID: 6278422
[TBL] [Abstract][Full Text] [Related]
38. The helper virus envelope glycoprotein affects the disease specificity of a recombinant murine leukemia virus carrying a v-myc oncogene.
Granger SW; Fan H
Virus Genes; 2001 Jun; 22(3):311-9. PubMed ID: 11450949
[TBL] [Abstract][Full Text] [Related]
39. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
Reddy EP; Smith MJ; Srinivasan A
Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
[TBL] [Abstract][Full Text] [Related]
40. Identification of a common helper provirus integration site in Abelson murine leukemia virus-induced lymphoma DNA.
Poirier Y; Kozak C; Jolicoeur P
J Virol; 1988 Nov; 62(11):3985-92. PubMed ID: 2845118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
